Business Context and Reporting Period
Company: Eastman Chemical Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Overview: Eastman is a global chemical company manufacturing chemicals, plastics, and fibers across five operating segments: Coatings, Adhesives, Specialty Polymers, and Inks (CASPI); Fibers; Performance Chemicals and Intermediates (PCI); Performance Polymers; and Specialty Plastics (SP). The company operates 13 manufacturing sites in eight countries. A significant corporate initiative involves industrial gasification to produce cost-advantaged chemicals from coal.
Key Financial Metrics
| Metric (in millions, except per share) | 2007 | 2006 |
|---|---|---|
| Sales Revenue | $6,830 | $6,779 |
| Operating Earnings | $504 | $654 |
| Earnings from Continuing Operations | $321 | $427 |
| Net Earnings | $300 | $409 |
| Diluted EPS (Continuing Ops) | $3.84 | $5.12 |
| Diluted EPS (Net) | $3.58 | $4.91 |
| Cash from Operating Activities | $732 | $609 |
| Capital Expenditures | $518 | $389 |
| Total Assets | $6,009 | $6,132 |
| Long-term Borrowings | $1,535 | $1,589 |
| Stockholders' Equity | $2,082 | $2,029 |
Margins: Gross profit margin was 17.5% in 2007 (down from 18.7% in 2006). Operating margin was 7.4% in 2007 (down from 9.6% in 2006).
Material Changes vs. Prior Period
- Revenue: Sales increased slightly by 1% ($51 million) to $6.83 billion. Excluding contract ethylene sales and divested product lines, organic sales increased 11% driven by higher volumes and prices.
- Profitability: Operating earnings declined 23% to $504 million. This decrease was primarily due to a significant operating loss in the Performance Polymers segment and higher raw material/energy costs ($250 million increase) that outpaced price increases ($200 million).
- Restructuring and Impairments: The company recorded $112 million in asset impairments and restructuring charges in 2007 (vs. $101 million in 2006), largely related to the divestiture of PET facilities in Mexico and Argentina. Accelerated depreciation costs were $49 million (vs. $10 million in 2006) due to the phase-out of cracking units and higher-cost PET assets.
- Divestitures: Completed the sale of PET facilities in Spain (discontinued operations) and Mexico/Argentina (continuing operations). Entered agreements to sell PET facilities in the Netherlands and UK (held for sale).
- Cash Flow: Operating cash flow improved by $123 million to $732 million, driven by an $86 million reduction in working capital, primarily inventory.
Guidance, Outlook, and Risks
2008 Outlook:
- Earnings: Management expects full-year 2008 earnings per share to be similar to 2007, excluding gains and charges related to strategic decisions.
- Performance Polymers: Plans to improve profitability by completing divestitures of underperforming assets outside the U.S., debottlenecking the new IntegRex technology facility in South Carolina, and shutting down 300,000 metric tons of higher-cost PET capacity.
- Capital Spending: Expected to exceed $600 million to fund growth initiatives, including industrial gasification projects and capacity expansions.
- Segments: Expects PCI margins at the high end of the 5-10% range; CASPI margins at the low end of the 15-20% range; and SP margins to improve toward 10-15% over time.
Key Risks and Contingencies:
- Raw Material Volatility: Significant exposure to fluctuations in raw material and energy costs (approx. 70% of total cost of operations).
- Industrial Gasification Projects: Two major projects (Beaumont, TX and St. James Parish, LA) totaling ~$3.2 billion in capital costs are in development. Risks include financing availability, regulatory approvals, and construction delays.
- Legal/Environmental: Ongoing asbestos litigation (management believes no material impact) and environmental remediation obligations (reserve of $42 million).
- Market Cyclicality: Performance of PCI and Performance Polymers segments is sensitive to global economic conditions and petrochemical cycles.
Investor Verification Checklist
- Performance Polymers Turnaround: Verify the timeline and cost savings associated with the shutdown of high-cost PET assets and the ramp-up of the IntegRex technology facility.
- Divestiture Completion: Confirm the closing of the Netherlands and UK PET facility sales and the final purchase price adjustments for the Mexico/Argentina sale.
- Gasification Project Financing: Monitor progress on securing non-recourse financing for the two industrial gasification projects, as delays could impact long-term growth strategy.
- Raw Material Hedging: Review the effectiveness of hedging strategies in mitigating the impact of volatile propane, natural gas, and paraxylene prices on gross margins.
- Working Capital Management: Assess whether the 2007 reduction in inventory was a one-time event or indicative of a sustained improvement in supply chain efficiency.